In NASH with liver fibrosis, resmetirom improved NASH resolution and reduced fibrosis at 1 y
{{output}}
Harrison SA, Bedossa P, Guy CD, et al. MAESTRO-NASH Investigators. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N Engl J Med. 2024;390:497-509. 38324483. ... ...
